Inhibition of necroptosis with the RIPK1 inhibitor necrostatin-1 or by genetic deletion of either Ripk3 or Mlkl provides protection against AP by reducing acinar cell vacuolization and necrosis15–19. Here, MLKL is linked to alkaline phosphatase measurement.